Company Filing History:
Years Active: 2017-2025
Title: **Innovative Contributions of Arindam Halder in Ophthalmic Solutions**
Introduction
Arindam Halder, an accomplished inventor based in Baroda, India, has made significant strides in the field of ophthalmology with his groundbreaking patents. With a total of 12 patents to his name, Halder is recognized for his innovative approaches to treating inflammatory disorders of the eye and enhancing the bioavailability of ophthalmic medications.
Latest Patents
Among his latest contributions is a pioneering ophthalmic solution of difluprednate, aimed at providing relief for inflammatory disorders of the eye. This invention includes a method of treatment that involves administering an aqueous solution containing difluprednate as the sole active ingredient at a concentration of 0.02% to 0.04% weight by volume. Notably, the solution is free of oil and is designed for administration twice a day, ensuring effective treatment for patients in need.
In addition, Halder has developed a method for increasing the bioavailability and prolonging the ophthalmic action of drugs. This invention focuses on an aqueous suspension that includes reversible clusters of drug-loaded nano-resin particles. The clusters feature a D50 value of at least 2 micrometers, and the drug-loaded particles have a particle size distribution where the D90 value ranges from 70 to 900 nanometers. This innovative approach aims to enhance the efficacy of ocular treatments.
Career Highlights
Arindam Halder is affiliated with Sun Pharma Advanced Research Company Limited, where he leverages his expertise to drive innovation in ophthalmology. His commitment to research and development has positioned him as a key figure in the pharmaceutical industry, focused on advancing treatment methodologies that benefit patients.
Collaborations
Throughout his career, Halder has collaborated with talented professionals in his field, including Ajay Khopade and Ankit Shaileshkumar Shah. These collaborations have fostered an environment of innovation, leading to the development of effective ophthalmic treatments and advancing research initiatives within the company.
Conclusion
Arindam Halder's contributions to the field of ophthalmology underscore his role as a leading inventor in the industry. With his inventive solutions and dedication to improving patient care, Halder continues to drive innovation at Sun Pharma Advanced Research Company Limited, making a lasting impact on ocular health.